Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 31;19(2):4.
doi: 10.1007/s11934-018-0755-6.

Clinical and Pathologic Features of Primary Angiosarcoma of the Kidney

Affiliations
Review

Clinical and Pathologic Features of Primary Angiosarcoma of the Kidney

Ayo O Omiyale et al. Curr Urol Rep. .

Abstract

Purpose of review: Primary angiosarcoma of the kidney is extremely rare; hence, relatively little is known regarding its clinicopathologic features and prognosis. Herein, we review the literature on primary renal angiosarcoma with emphasis on the clinical and pathologic features.

Recent findings: Approximately 64 cases have been reported in the literature, and most cases occur in the 6th-7th decade with a strong male predominance. The aetiology is unknown. Patients present with flank pain, haematuria, abdominal mass and weight loss. A considerable number of patients develop metastatic disease at diagnosis or shortly afterwards. Grossly, the tumour comprises ill-defined haemorrhagic spongy masses often with necrosis. Microscopically, the tumour is composed of anastomosing capillary-sized vessels which are lined by malignant endothelial cells. The mainstay of treatment is surgery followed by radiation therapy with or without chemotherapy. Renal angiosarcomas are highly aggressive tumours with dismal outcome, and they must be distinguished from morphologically similar lesions of the kidney.

Keywords: Renal angiosarcoma; Renal haemangioma; Renal hemangiosarcoma; Vascular tumour.

PubMed Disclaimer

References

    1. Int J Urol. 2006 Aug;13(8):1112-4 - PubMed
    1. Cancer Chemother Pharmacol. 2008 Apr;61(4):717-20 - PubMed
    1. Arch Pathol Lab Med. 1995 Jan;119(1):75-8 - PubMed
    1. Cancer Res. 2009 Sep 15;69(18):7175-9 - PubMed
    1. Can Urol Assoc J. 2014 Mar;8(3-4):E223-6 - PubMed

LinkOut - more resources